<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To explore the relationship between plasma total <z:chebi fb="0" ids="17230">homocysteine</z:chebi> concentration and <z:e sem="disease" ids="C0011882" disease_type="Disease or Syndrome" abbrv="">diabetic neuropathy</z:e> in Chinese patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Chinese patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (n=249) were enrolled in a cross-sectional hospital based study </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0011882" disease_type="Disease or Syndrome" abbrv="">Diabetic neuropathy</z:e> status was documented by presence of clinical signs and confirmed by electromyography </plain></SENT>
<SENT sid="3" pm="."><plain>Plasma total <z:chebi fb="0" ids="17230">homocysteine</z:chebi> concentration was measured using fluorescence polarization immunoassay </plain></SENT>
<SENT sid="4" pm="."><plain>Traditional risk factors for <z:e sem="disease" ids="C0011882" disease_type="Disease or Syndrome" abbrv="">diabetic neuropathy</z:e> were obtained from fasting blood samples and interviewer-questionnaire </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Plasma total <z:chebi fb="0" ids="17230">homocysteine</z:chebi> levels were higher in subjects with <z:e sem="disease" ids="C0011882" disease_type="Disease or Syndrome" abbrv="">diabetic neuropathy</z:e> than without (12.8 (9.2-14.8) μmol/l vs. 8.0 (7.7-9.1) μmol/l, p=0.005) </plain></SENT>
<SENT sid="6" pm="."><plain>The association of <z:chebi fb="0" ids="17230">homocysteine</z:chebi> with <z:e sem="disease" ids="C0011882" disease_type="Disease or Syndrome" abbrv="">diabetic neuropathy</z:e> was independent of major traditional risk factors for <z:e sem="disease" ids="C0011882" disease_type="Disease or Syndrome" abbrv="">diabetic neuropathy</z:e> (duration of <z:mp ids='MP_0002055'>diabetes</z:mp>, HbA1c) and determinants of higher <z:chebi fb="0" ids="17230">homocysteine</z:chebi> concentration (age, gender, serum <z:chebi fb="3" ids="37445">folate</z:chebi> and <z:chebi fb="9" ids="17439">vitamin B12</z:chebi>, renal status, and <z:chebi fb="0" ids="3095">Biguanide</z:chebi> use) (OR: 1.12 (1.00-1.25), p=0.042) </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, per increase of 4.0 μmol/l plasma <z:chebi fb="0" ids="17230">homocysteine</z:chebi> was related to <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e>, after controlling for per unit increase of other factors (OR: 1.17 (0.94-1.33), p=0.045) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: Plasma total <z:chebi fb="0" ids="17230">homocysteine</z:chebi> concentration was independently associated with occurrence of <z:e sem="disease" ids="C0011882" disease_type="Disease or Syndrome" abbrv="">diabetic neuropathy</z:e> in Chinese people </plain></SENT>
<SENT sid="9" pm="."><plain>Future prospective studies are warranted to clarify the relationship </plain></SENT>
</text></document>